RAS pathway inhibitor

This page covers all RAS pathway inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting KRAS.

Targets

KRAS

Marketed (1)

• RAS 2410 · Nan Chen,MD · Oncology
  RAS 2410 is a selective inhibitor of the RAS pathway.

Patent intelligence

• ras pathway inhibitor patent landscape — aggregated cliff calendar, attackable patents, originator estates